Manufacture high-performance polymers and specialty chemical products. Produce advanced polyamide granulates for various applications. Now — the numbers.
This is an established company with proven profits.
An average decline of 4% a year over the last 4 years — the most striking risk in this picture.
If every debt were paid off today, $724.8M would still be left in the vault — a solid cushion for hard times.
The market pays 40× for every dollar this company earns in a year — a price that already assumes things go well.
No analyst target is on record for this company.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are going backwards, not just slowing.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
The net profit margin is 24% — still a thick cushion, though costs have been eating into it lately.
There is $764.6M in the vault; even if every debt were paid off, $724.8M would remain.
It pays out $22.67 per share each year — regular cash for whoever holds the stock.
Over the last 4 years, sales fell about 4% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
The company’s market value is 40 times its annual profit. Even a small disappointment could hit the price hard.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.